Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Voss

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|October 19, 2019
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with BevacizumabMartin Voss, AbdulAziz Batarfi, Eike Steidl, et al.
European Journal of Immunology|November 19, 2015
The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3Anna Paeschke, Anna Possehl, Karin Klingel, et al.
The FEBS Journal|January 23, 2022
A cytosolic disulfide bridge-supported dimerization is crucial for stability and cellular distribution of Coxsackievirus B3 protein 3AMartin Voss, Gunnar Kleinau, Niclas Gimber, et al.
Biological Psychiatry|July 16, 2018
The Predictive Coding Account of PsychosisPhilipp Sterzer, Rick A Adams, Paul Fletcher, et al.
International Journal of Molecular Sciences|May 19, 2018
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible SystemsAnna-Luisa Luger, Benedikt Sauer, Nadja I Lorenz, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Protein phosphatase 4 is phosphorylated and inactivated by Cdk in response to spindle toxins and interacts with γ-tubulinMartin Voss, Kathryn Campbell, Nastja Saranzewa, et al.
Current Neuropharmacology|October 16, 2015
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?Christian Knöchel, Martin Voss, Florian Grüter, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Neurosurgical Review|April 26, 2021
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastomaDaniel Dubinski, Sae-Yeon Won, Martin Voss, et al.
Current Alzheimer Research|June 24, 2016
Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and DementiaChristian Knöchel, Martin Voss, Florian Gruter, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|October 19, 2019
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with BevacizumabMartin Voss, AbdulAziz Batarfi, Eike Steidl, et al.
European Journal of Immunology|November 19, 2015
The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3Anna Paeschke, Anna Possehl, Karin Klingel, et al.
The FEBS Journal|January 23, 2022
A cytosolic disulfide bridge-supported dimerization is crucial for stability and cellular distribution of Coxsackievirus B3 protein 3AMartin Voss, Gunnar Kleinau, Niclas Gimber, et al.
Biological Psychiatry|July 16, 2018
The Predictive Coding Account of PsychosisPhilipp Sterzer, Rick A Adams, Paul Fletcher, et al.
International Journal of Molecular Sciences|May 19, 2018
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible SystemsAnna-Luisa Luger, Benedikt Sauer, Nadja I Lorenz, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Protein phosphatase 4 is phosphorylated and inactivated by Cdk in response to spindle toxins and interacts with γ-tubulinMartin Voss, Kathryn Campbell, Nastja Saranzewa, et al.
Current Neuropharmacology|October 16, 2015
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?Christian Knöchel, Martin Voss, Florian Grüter, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Neurosurgical Review|April 26, 2021
Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastomaDaniel Dubinski, Sae-Yeon Won, Martin Voss, et al.
Current Alzheimer Research|June 24, 2016
Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and DementiaChristian Knöchel, Martin Voss, Florian Gruter, et al.
Pageof 11